33
/pt/
AIzaSyB4mHJ5NPEv-XzF7P6NDYXjlkCWaeKw5bc
November 1, 2025
2135666
178559
2
Public Timelines
FAQ Receber premium

8 jun 2017 ano - FDA requested that Endo Pharmaceuticals remove its opioid pain medication, reformulated Opana ER (oxymorphone hydrochloride), from the market based on its concern that the benefits of the drug may no longer outweigh its risks.

Adicionado na linha do tempo:

13 nov 2018
0
0
521

Data:

8 jun 2017 ano
Agora
~ 8 years and 4 months ago